| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing isosorbide mononitrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Accidental nitrate poisoning |
Causative agent (attribute) |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Intentional nitrate poisoning |
Causative agent (attribute) |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Nitrate poisoning of undetermined intent |
Causative agent (attribute) |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
1 |
| Nitrate vasodilator adverse reaction |
Causative agent (attribute) |
True |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
1 |
| Isosorbide dinitrate adverse reaction |
Causative agent (attribute) |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Parenteral isosorbide dinitrate adverse reaction |
Causative agent (attribute) |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Oral isosorbide dinitrate adverse reaction |
Causative agent (attribute) |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Modified release isosorbide dinitrate adverse reaction |
Causative agent (attribute) |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Isosorbide mononitrate adverse reaction |
Causative agent (attribute) |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Modified release isosorbide mononitrate adverse reaction (disorder) |
Causative agent (attribute) |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Nitrate vasodilator allergy |
Causative agent (attribute) |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Isosorbide dinitrate allergy |
Causative agent (attribute) |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Parenteral isosorbide dinitrate allergy |
Causative agent (attribute) |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Oral isosorbide dinitrate allergy |
Causative agent (attribute) |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Modified release isosorbide dinitrate allergy |
Causative agent (attribute) |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Isosorbide mononitrate allergy |
Causative agent (attribute) |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Modified release isosorbide mononitrate allergy |
Causative agent (attribute) |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Nitrate overdose |
Causative agent (attribute) |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
1 |
| Isosorbide dinitrate overdose (disorder) |
Causative agent (attribute) |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Isosorbide mononitrate overdose |
Causative agent (attribute) |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Isosorbide mononitrate 60mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Isosorbide mononitrate 40mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Isosorbide mononitrate 25mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Isosorbide mononitrate 50mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Isosorbide mononitrate 50mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Isosorbide mononitrate 40mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Isosorbide mononitrate 25mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Isosorbide mononitrate 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Isosorbide mononitrate 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Isosorbide mononitrate 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Isosorbide mononitrate 60mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Product containing aspirin and isosorbide mononitrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Isosorbide mononitrate+aspirin 60mg/150mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Isosorbide mononitrate+aspirin 60mg/75mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Isosorbide dinitrate [generic additions] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Isosorbide dinitrate 5mg sublingual tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Isosorbide dinitrate 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Isosorbide dinitrate 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Isosorbide dinitrate 30 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Isosorbide dinitrate 20mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Isosorbide dinitrate 500micrograms/mL injection solution 50mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Isosorbide dinitrate 1.25 mg/actuation sublingual spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Isosorbide dinitrate 30mg transdermal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Isosorbide dinitrate 40mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Isosorbide dinitrate 1mg/mL injection solution 10mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Isosorbide dinitrate 1mg/mL injection solution 50mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Nitrate-based vasodilating agent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Modified release isosorbide dinitrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Product containing isosorbide dinitrate in parenteral dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Modified release isosorbide mononitrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Product containing isosorbide dinitrate in oral dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Transdermal isosorbide dinitrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Isosorbide dinitrate 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Product containing precisely isosorbide dinitrate 2.5 milligram/1 each conventional release sublingual tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Isosorbide dinitrate 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Isosorbide mononitrate 30mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Isosorbide dinitrate 40mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Pentaerithrityl tetranitrate |
Is a |
True |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Glyceryl trinitrate |
Is a |
True |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Isosorbide mononitrate 120mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Product containing isosorbide dinitrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Poisoning by nitrate |
Causative agent (attribute) |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Inositol hexanitrate |
Is a |
True |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Eritrityl tetranitrate |
Is a |
True |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Amyl nitrite (substance) |
Is a |
True |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Methemoglobinemia due to nitrate poisoning (disorder) |
Causative agent (attribute) |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
1 |
| Amyl nitrate |
Is a |
True |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Isosorbide dinitrate (substance) |
Is a |
True |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Product containing precisely inositol niacinate 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Product containing precisely inositol niacinate 750 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Inositol nicotinate 200 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Product containing inositol niacinate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Isosorbide mononitrate (substance) |
Is a |
True |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
| Accidental nitrate poisoning |
Causative agent (attribute) |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
1 |
| Intentional nitrate poisoning |
Causative agent (attribute) |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
1 |
| Poisoning caused by nitrate vasodilator |
Causative agent (attribute) |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
1 |
| Nitrate vasodilator allergy |
Causative agent (attribute) |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
1 |
| Nitrate vasodilator overdose |
Causative agent (attribute) |
True |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
1 |
| Accidental nitrate vasodilator poisoning |
Causative agent (attribute) |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
1 |
| Intentional nitrate vasodilator poisoning |
Causative agent (attribute) |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]